Pelvis vein thrombosis in spite of anticoagulant therapy in a 17-year-old patient;Beckenvenenthrombose trotz antikoagulatorischer Therapie bei einem 17jahrigen Patienten

Internist

Volumn 38, Issue 1, 1997, Pages 77-80

  Eschrich, S ^a   Zouboulis, Ch C ^b   Schweiger, U ^a   Riess, H ^a   Huhn, D ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; PREDNISOLONE;

ADOLESCENT; ARTICLE; BEHCET DISEASE; CASE REPORT; DEEP VEIN THROMBOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PELVIS;

ADOLESCENT; BEHCET SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMORAL VEIN; HUMANS; ILIAC VEIN; MALE; PHLEBOGRAPHY; SAPHENOUS VEIN; THROMBOSIS;

EID: 0031050162     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Adamantiades B (1931) Sur un cas d'irite à hypopyon récidivant. Ann Oculist (Paris) 168:271-278
2. Adamantiades B (1946) La thrombophlébite comme quatrième symptome de l'irite récidivante à hypopyon. Ann Oculist (Paris) 179:143-148
3. Aydìntug AO, Tokgöz G, D'Cruz DP, Gürler A, Cervera R, Düzgün N, Atmaca LS, Khamashta MA, Huges GRV (1993) Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol 67:157-162
4. Bayraktar Y, Balkanci F, Dündar S, Kansu E, Telatar H (1991) Angiographic findings of great vessel involvement in Behçet's disease. Vasc Surg 25:119-125
5. Behçet H (1937) Über rezidivierende, aphthöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152-1157
6. Chajek-Shaul T, Pisanty S, Knobler H, Matzner Y, Glick M, Ron N, Rosenman E, Brautbar C (1987) HLA-B51 may serve as an immunogenic marker for a subgroup of patients with Behçet's syndrome. Am J Med 83:666-672
7. Cunliffe WJ, Menon IS (1969) Treatment of Behçet's syndrome with phenformin and ethylestrenol. Lancet 1:1239-1240
8. Efthimiou J, Johnston C, Spiro SG, Turner-Warwick M (1986) Pumonary disease in Behçet's syndrome. Q J Med 58:259-280
9. Gupta RC, O'Duffy JD, McDuffie FC, Meurer M, Jordon RE (1978) Circulating immune complexes in active Behçet's disease. Clin Exp Immunol 34:213-218
10. International Study Group for Behçet's disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
11. Jorizzo JI, Solomon AR, Cavallo T (1985) Behçet's syndrome: immunopathologic and histopathologic assessment of pathergy lesions in useful in diagnosis and follow-up. Arch Pathol Lab Med 109:983-1005
12. Kabbaj N, Benjelloun G, Gueddari FZ, Dafiri R, Imani F (1993) Les atteintes vasculaires de la maladie de Behçet. A propos de 40 dossiers. J Radiol 74:649-656
13. Katzenellenbogen I, Feuerman EJ (1965) Beitrag zum M. Behçet. (Die Bedeutung der spezifischen Hauthyperreaktivität und der Behçetinreaktion). Hautarzt 16:13-18
14. Kienbaum S, Zouboulis CC, Waibel M, Orfanos CE (1993) Chemotactic neurotrophilic vasculitis: a new histopathological pattern of vasculitis found in mucocutaneous lesions of patients with Adamantiades-Behçet's disease. In: Wechsler B, Godeau P (eds) Behçet's disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York, pp 337-341
15. Koç Y, Güllü I, Akpek G, Akpolat T, Kansu E, Kiraz E, Batman F, Kansu T, Balkanci F, Akkaya S, Telatar H, Zileli T (1992) Vascular involvement in Behçet's disease. J Rheumatol 19:402-410
16. Lambert D, Rifle G, Guiod-Deschamps I, Collet E (1990) Plasma exchange in patients with Behçet's disease (letter). J Am Acad Dermatol 22:1123
17. Lehner T, Almeida JD, Levinsky RJ (1978) Damaged membrane fragments and immune complexes in the blood of patients with Behçet's syndrome. Clin Exp Immunol 34:206-212
18. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M (1982) Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 100:1455-1458
19. Plotkin GR (1988) Miscellaneous clinical manifestations, part I: cardiac, vascular, renal, and pulmonary features. In: Plotkin GR, Calabro JJ, O'Duffy JD (eds) Behçet's disease. A contemporary synopsis. Futura, Mount Kisco, NY, pp 239-279
20. Rosenthal T, Halkin H, Shani M, Deutch V (1972) Occlusion of the great veins in the Behçet syndrome. Angiology 23:600-605
21. Taylor PV, Chamberlain MA, Scott JS (1993) Autoreactivity in patients with Behçet's disease. Br J Rheumatol 32:908-910
22. Wechsler J, Wechsler B, Herreman G, Godeau P, Touraine R, Pinaudeau Y (1981) Maladie de Behçet. Etude en immunofluorescence de l'intradermo-réaction à l'eau distilée. Valeur diagnostique à pro pos de 50 malades. Med Interne 16:112-117
23. Yazici H, Pazarli H, Barnes CG, Tüzün Y, Özyazgan Y, Silman A, Serdaroglu S, Oguz V, Yurdakul S, Lovatt GE, Yazici B, Somani S, Müftüoglu A (1990) A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 322:281-285
24. Yacici H, Barnes CG (1991) Practical treatment recommendations for pharmacotherapy of Behçet's syndrome. Drugs 42:796-804
25. Zouboulis ChC (1995) Morbus Adamantiades-Behçet. Klinische und experimentelle Befunde von 53 Patienten aus dem Berliner Raum. Habilitationsschrift, Universitäts-Hautklinik und Poliklinik, Klinikum Benjamin Franklin, Freie Universität Berlin
26. Zouboulis ChC, Orfanos CE (1995) Maligne Aphthose: M. Behçet. In: Orfanos CE, Garbe C (Hrsg) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York, pp 525-531
27. Zouboulis ChC, Treudler R, Orfanos CE (1993) Morbus Adamantiades-Behçet. Therapeutischer Einsatz von systemischem rekombinantem Interferon-α-2a. Hautarzt 44:450-445
28. Zouboulis ChC, Büttner P, Djawari O, Kirch W, Keitel W, Garbe C, von Kayserlingk-Eberius H-J, Orfanos CE (1993) HLA-Muster bei Morbus Adamantides-Behçet in Deutschland: Assoziation zum Auftreten, der klinischen Symptomatik und dem Krankheitsverlauf bei 39 Patienten. Hautarzt 44:81-85 und 265 (Erratum)